STAT1 and m<sup>6</sup>A-mediated IL15RA upregulation promotes metastasis via ZEB1/NF-κΒ axis in ccRCC.
Ontology highlight
ABSTRACT: Interleukin-15 receptor alpha (IL15RA) demonstrates critical regulatory function in oncogenesis and immunomodulation across various malignancies. However, the role of IL15RA in cancers, such as Clear Cell Renal Cell Carcinoma (ccRCC) remains unclear. Therefore, integrated pan-cancer analysis and mechanism investigation assays are essential for IL15RA-directed therapeutic strategy optimization in ccRCC. The comprehensive pan-cancer analysis reveals IL15RA as a plausible diagnostic and prognostic biomarker, as well as a promising immunotherapeutic target across various cancers, particularly ccRCC. IL15RA promotes ccRCC metastasis based on the data of the investigation. Mechanistically, STAT1 binds to IL15RA promoter region, thereby enhancing IL15RA mRNA expression, while METTL3 modulates RNA
SUBMITTER: Wei J
PROVIDER: S-EPMC12575848 | biostudies-literature | 2025 Oct
REPOSITORIES: biostudies-literature
ACCESS DATA